Literature DB >> 7979835

Management of adverse reactions to trimethoprim-sulfamethoxazole in human immunodeficiency virus-infected patients.

A C Jung1, D S Paauw.   

Abstract

Trimethoprim-sulfamethoxazole is an important medication for the treatment and prevention of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome. Use of this medication has been limited by the high frequency of adverse reactions that occur in patients with human immunodeficiency virus disease. This article reviews the incidence and spectrum of adverse reactions and options for continuing therapy with trimethoprim-sulfamethoxazole in human immunodeficiency virus-infected patients who have adverse reactions.

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7979835

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN： 0003-9926


  11 in total

Review 1.  Prophylaxis of Pneumocystis carinii pneumonia: too much of a good thing?

Authors:  R F Miller
Journal:  Thorax       Date:  2000-08       Impact factor: 9.139

2.  Validation of the MycAssay Pneumocystis kit for detection of Pneumocystis jirovecii in bronchoalveolar lavage specimens by comparison to a laboratory standard of direct immunofluorescence microscopy, real-time PCR, or conventional PCR.

Authors:  Lisa R McTaggart; Nancy L Wengenack; Susan E Richardson
Journal:  J Clin Microbiol       Date:  2012-03-14       Impact factor: 5.948

Review 3.  Cotrimoxazole. Rationale for re-examining its indications for use.

Authors:  R A Howe; R C Spencer
Journal:  Drug Saf       Date:  1996-04       Impact factor: 5.606

4.  Trimethoprim/sulfamethoxazole induced multiorgan dysfunction.

Authors:  Joshua Seung Oh Lee; David Owshalimpur; Christina Schofield
Journal:  BMJ Case Rep       Date:  2012-12-18

5.  Detection of Pneumocystis jirovecii by Quantitative PCR To Differentiate Colonization and Pneumonia in Immunocompromised HIV-Positive and HIV-Negative Patients.

Authors:  T Fauchier; L Hasseine; M Gari-Toussaint; V Casanova; P M Marty; C Pomares
Journal:  J Clin Microbiol       Date:  2016-03-23       Impact factor: 5.948

Review 6.  Allergic adverse reactions to sulfonamides.

Authors:  Geneviève Choquet-Kastylevsky; Thierry Vial; Jacques Descotes
Journal:  Curr Allergy Asthma Rep       Date:  2002-01       Impact factor: 4.919

7.  Friendly fire.

Authors:  Alexander Woywodt; Helen Alderson; Liz Lamerton; Zoe Thain; Grahame Wood
Journal:  NDT Plus       Date:  2011-03-17

Review 8.  Managing drug reactions to sulfonamides and other drugs in HIV infection: desensitization rather than rechallenge?

Authors:  P P Koopmans; D M Burger
Journal:  Pharm World Sci       Date:  1998-12

9.  Evaluation of Trimethoprim/Sulfamethoxazole (SXT), Minocycline, Tigecycline, Moxifloxacin, and Ceftazidime Alone and in Combinations for SXT-Susceptible and SXT-Resistant Stenotrophomonas maltophilia by In Vitro Time-Kill Experiments.

Authors:  Chuanqi Wei; Wentao Ni; Xuejiu Cai; Jin Zhao; Junchang Cui
Journal:  PLoS One       Date:  2016-03-21       Impact factor: 3.240

Review 10.  Trimethoprim-sulfamethoxazole induced circulatory shock in a human immunodeficiency virus uninfected patient: a case report and review.

Authors:  Patricia Liu; Gregory P Ranches; Jeffrey A Gold
Journal:  BMC Pharmacol Toxicol       Date:  2018-11-20       Impact factor: 2.483
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.